.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Infant Aphakia Treatment Study followed children who underwent unilateral cataract surgery in infancy and were managed with aphakia and contact-lens correction. Ten-year follow-up showed a progressive reduction in hyperopic refractive error over childhood, with the fastest myopic shift occurring during the earliest years. This long-term observation is highly relevant to pediatric cataract management because refractive planning in infants cannot rely on a static postoperative target. The eye continues to grow, and the optical correction chosen at infancy must be adaptable to future biometric changes. For HCPs, the study emphasizes that visual rehabilitation, refractive monitoring, amblyopia treatment, and family adherence extend far beyond the initial cataract surgery. The refractive trajectory also helps explain why some infants may remain aphakic initially and later undergo secondary IOL implantation. In practical terms, parents should be counseled that the treatment pathway is longitudinal and that regular examinations are necessary to keep the optical correction aligned with ocular growth and visual development. The study provides strong evidence for viewing pediatric cataract care as a developmental process rather than a one-time operation.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Infant Aphakia Treatment Study followed children who underwent unilateral cataract surgery in infancy and were managed with aphakia and contact-lens correction. Ten-year follow-up showed a progressive reduction in hyperopic refractive error over childhood, with the fastest myopic shift occurring during the earliest years. This long-term observation is highly relevant to pediatric cataract management because refractive planning in infants cannot rely on a static postoperative target. The eye continues to grow, and the optical correction chosen at infancy must be adaptable to future biometric changes. For HCPs, the study emphasizes that visual rehabilitation, refractive monitoring, amblyopia treatment, and family adherence extend far beyond the initial cataract surgery. The refractive trajectory also helps explain why some infants may remain aphakic initially and later undergo secondary IOL implantation. In practical terms, parents should be counseled that the treatment pathway is longitudinal and that regular examinations are necessary to keep the optical correction aligned with ocular growth and visual development. The study provides strong evidence for viewing pediatric cataract care as a developmental process rather than a one-time operation.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
